Furthermore, overall survival analysis via UALCAN revealed that high expression of RNASEK was associated with good prognosis in three cancers, namely, kidney renal papillary cell carcinoma (KIRP) (P = 0.014), OV (P = 0.015) (Appendix D), and PAAD (P = 0.01) (Figure 5C), whereas poor prognosis was detected in ESCA (P = 0.039), KICH (P = 0.019), and READ (P = 0.029) (Appendix D). This evidence concerns the gene RNASEK and cancer.